Lee M Y, Alejandro R, Toomey N L
Department of Medicine, University of Miami School of Medicine, Florida 33101.
Arch Biochem Biophys. 1989 Jul;272(1):1-9. doi: 10.1016/0003-9861(89)90187-2.
A panel of murine hybridoma cell lines which produce antibodies against polypeptides present in human placental DNA polymerase delta preparations was developed. Eight of these antibodies were characterized by virtue of their ability to inhibit DNA polymerase delta activity and immunoblot the 170-kDa catalytic polypeptide. Six of these eight antibodies inhibit DNA polymerase delta but not DNA polymerase alpha, showing that the two proteins are distinct. However, the other two monoclonal antibodies inhibited both DNA polymerase delta and alpha activities, providing the first evidence that these two proteins have a structural relationship. In addition to antibodies against the catalytic polypeptide we also identified 11 antibodies which recognize 120-, 100-, 88-, 75-, 62-, 36-, and 22-kDa polypeptides in DNA polymerase delta preparations, suggesting that these proteins might be part of a replication complex. The antibody to the 36-kDa polypeptide was shown to be directed against proliferating cell nuclear antigen/cyclin. These antibodies should prove useful for studies aimed at distinguishing between DNA polymerases alpha and delta and for the investigation of the functional roles of DNA polymerase delta polypeptides.
建立了一组鼠杂交瘤细胞系,这些细胞系可产生针对人胎盘DNA聚合酶δ制剂中存在的多肽的抗体。其中八种抗体通过其抑制DNA聚合酶δ活性和对170 kDa催化多肽进行免疫印迹的能力进行了表征。这八种抗体中的六种抑制DNA聚合酶δ但不抑制DNA聚合酶α,表明这两种蛋白质是不同的。然而,另外两种单克隆抗体同时抑制了DNA聚合酶δ和α的活性,这首次证明了这两种蛋白质具有结构关系。除了针对催化多肽的抗体外,我们还鉴定出11种抗体,它们可识别DNA聚合酶δ制剂中的120 kDa、100 kDa、88 kDa、75 kDa、62 kDa、36 kDa和22 kDa多肽,这表明这些蛋白质可能是复制复合物的一部分。已证明针对36 kDa多肽的抗体是针对增殖细胞核抗原/细胞周期蛋白的。这些抗体对于区分DNA聚合酶α和δ以及研究DNA聚合酶δ多肽的功能作用的研究应该是有用的。